(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide

(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide

AT60186

CAS 1934246-20-4

More details

1000 Items

$128.70

$128.70 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
15 $84.15 Total: $420.75
110 $71.28 Total: $712.80
125 $60.39 Total: $1,509.75
150 $51.48 Total: $2,574.00
1100 $44.55 Total: $4,455.00

Overview

MitoBloCK-6 is an effective inhibitor of Erv1ALR with IC50 values of 900 nM and 700 nM, respectively. Additionally, MitoBloCK-6 inhibits Erv2 (IC50=1.4 ?M). It induces apoptosis in hESCs by promoting the release of cytochrome c.

Chemical Properties

Molecular FormulaC26H23F3N6O
Molecular Weight492.5
CAS Numbers1934246-20-4
SolubilityDMSO
Purity98% by HPLC
SMILES CodeC[C@H]1C=2C(CN(C1)C=3C=NC=NC3)=CC(C(NC4=CC(=CC(C(F)(F)F)=C4)N5C=NC(C)=C5)=O)=CC2

Storage and Handling

0C Short Term, -20C Long Term

References

Wang Z, Bian H, Bartual SG, Du W, Luo J, Zhao H, Zhang S, Mo C, Zhou Y, Xu Y, Tu Z, Ren X, Lu X, Brekken RA, Yao L, Bullock AN, Su J, Ding K. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 [DDR1] Inhibitors. J Med Chem. 2016 Jun 23;59[12] 5911-6. doi 10.1021acs.jmedchem.6b00140. Epub 2016 Jun 3. PMID 27219676; PMCID PMC5053573.